Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Careers
Technology
NETs Platform
SubB2M Platform
hTERT ICC Assay
Intellectual Property
Publications & Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-OC™ Ovarian Cancer Screening Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
5-Nov-2026
Addendum to Notice of Annual General Meeting/Proxy Form
2-Nov-2026
Initial Director's Interest Notice - A. Chapman
2-Nov-2026
IIQ signs EXO-OC validation agreement with Sonic Healthcare
30-Oct-2026
Board Changes
29-Oct-2026
Quarterly Activities Report and Appendix 4C - September 2026
26-Oct-2026
INOVIQ receives $1.782m R&D Tax Incentive Refund
23-Oct-2026
Notice of Annual General Meeting/Proxy Form
23-Oct-2026
INOVIQ Announces Leadership Change
30-Sep-2026
EXO-OC Technical Review and Commercialisation Pathway
17-Sep-2026
2026 Annual Report
1
2
3
Next